spacer
 
|

Managing Excessive Daytime Sleepiness in Patients with Narcolepsy:
Insights for Neuroscience Nurses

Supported by an educational grant from Jazz Pharmaceuticals.

OVERVIEW
Poor sleep quality and excessive daytime sleepiness (EDS) are associated with cardiovascular events, poor academic performance, psychological distress, and motor vehicle accidents. The cornerstone of evaluating and managing EDS is to identify the underlying condition(s), of which narcolepsy is a part of the differential diagnosis. The Narcolepsy Network, a nonprofit patient support organization, indicates that only 25% of people in the United States who have narcolepsy have been diagnosed and are receiving treatment. Further complicating matters, the diagnosis of EDS and underlying narcolepsy can sometimes be challenging for providers because symptoms are subjective, there are inconsistencies in terminology, and there is a lack of consensus on methods of diagnosis and assessment. In this interactive webcast, expert faculty will provide the latest updates and insights on diagnosing patients with narcolepsy, specifically addressing basic sleep structure, homeostatic and circadian control of the sleep/wake cycle, as well as pathophysiology and genetics. Management strategies of related symptoms and the prevalence and incidence of narcolepsy in adults and children will also be discussed as well methods to overcome various challenges presented in diagnosing and treating adolescents. Participants will also be provided with the most current and emerging treatment options and practice parameters to optimize outcomes for patients suffering with narcolepsy and related symptoms.

GOAL
This educational activity will provide advanced practice nurses and other neuroscience nurses with up-to-date information on current trends in the treatment and management of patients with excessive daytime sleepiness.

INTENDED AUDIENCE
This activity is designed for advanced practice nurses and other neuroscience nurses who manage patients with excessive daytime sleepiness. No prerequisites required.

LEARNING OBJECTIVES
After participating in this activity, the participant will demonstrate the ability to:
  • RECOGNIZE symptoms associated with EDS related to narcolepsy and the importance of differential diagnosis.
  • COMPARE current guideline-based therapy with emerging therapies used in the management of EDS related to narcolepsy.
  • IDENTIFY supportive care strategies nurses can adopt to manage their patients with EDS related to narcolepsy.

APPROVAL STATEMENT
The American Association of Neuroscience Nurses (AANN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Attendees can earn 1.5 nursing contact hours from AANN by completing and submitting to AANN the evaluation form for this session.

CREDIT DESGINATION STATEMENT
This 1.5 contact hour educational activity is approved by the American Association of Neuroscience Nurses. Claim only those contact hours actually spent in the activity.

This activity has been submitted to the American Association of Neuroscience Nurses for approval to award contact hours. The American Association of Neuroscience Nurses is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

(For more information regarding contact hours, please contact Melinda Ciattarelli at mcastro@asimcme.com or 908-253-9001 x 38).

Association of Neuroscience Nurses. Claim only those contact hours actually spent in the activity.

The estimated time to complete this activity: 90 minutes

Release date: May 1, 2015.       Expiration date: May 1, 2017.

HOW TO RECEIVE CONTACT HOURS
Please select “Continue to pre-test” below to complete a brief pre-assessment before continuing with the webcast archive. After listening to and viewing this activity, participants may receive contact hours by completing the CNE test, evaluation, and receiving a score of 70% or higher. Certificates can be printed immediately online.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

FACULTY
Policy on Faculty and Provider Disclosure
AANN requires disclosure from faculty of the existence of any significant financial interest or other relationship a faculty member has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation, or of any significant financial interest or other relationship a faculty member may have with the commercial supporter. AANN also requires disclosure of the intent to discuss unlabeled uses of a commercial product or an investigational use of a product not yet approved for this purpose. The material presented in this activity represents the opinion of the speakers and not necessarily the views of AANN. The Participating Faculty reported the following:

STEERING COMMITTEE
Terri E. Weaver, PhD, RN, FAAN (Chair)
Dean and Professor
University of Illinois College of Nursing
Chicago, Illinois
Dr Weaver reports receiving research equipment from Philips Respironics, Inc; and for receiving grants/research support from Teva, Inc.

Christina Calamaro, PhD, CRNP (Content Author)
Director of Nursing
Nemours/Alfred I. DuPont
Hospital for Children
Wilmington, Delaware
Dr Calamaro reports having no relevant financial or advisory relationships with corporate organizations related to this activity.

Mary C. Kapella, PhD, MS, RN (Presenter)
Assistant Professor
Department of Biobehavioral
Health Science
Center for Narcolepsy, Sleep and Health Research
University of Illinois at Chicago
College of Nursing
Chicago, Illinois
Dr Kapella reports having no relevant financial or advisory relationships with corporate organizations related to this activity.

Kathy P. Parker, PhD, RN, APRN, FAAN, FAASM (Content Author)
Dean and Professor
School of Nursing
University of Rochester
Rochester, New York
Dr Parker reports having no relevant financial or advisory relationships with corporate organizations related to this activity.

Ann E. Rogers, PhD, RN, FAAN , FAASM (Presenter)
Edith F. Honeycutt Chair in Nursing
Professor and Director of Graduate Studies
Nell Hodgson Woodruff School of Nursing
Emory University
Atlanta, Georgia
Dr Rogers reports having no relevant financial or advisory relationships with corporate organizations related to this activity.

Loretta J. Colvin, APRN-BC, NP (Content Author)
Clinical Consultant Nurse Practitioner
Clayton Sleep Institute
Director, CSI Knowledge Center
St. Louis, Missouri
Ms Colvin reports having no relevant financial or advisory relationships with corporate organizations related to this activity.

Off-Label Product Discussion: The audience is advised that faculty in this CNE activity may include reference(s) to unlabeled, unapproved, or investigational uses of therapeutic agents or biomedical devices. The presnters will inform the audience of when they discuss or reference an unapproved, unlabeled, or investigational use of therapeutic agent or biomedical device.

ACTIVITY INFORMATION
Fee Information: There is no fee for participating in this activity.

Copyright Information: All rights reserved. No part of this syllabus may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

Privacy Policy: ASiM protects the privacy of personal and other information regarding participants and educational collaborators. ASiM will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the ACCME.

ASiM maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse of alteration of information that we have collected from you.

Contact Information: If you have questions about this CNE activity, please contact at 908-253-9001 or webmaster@asimcme.com.

Hardware and Software Requirements: Pentium 800 processor or greater, Windows 98/NT/200/XP or Mac OS 9/X or later, Microsoft Internet Explorer, Safari, Firefox, Windows Media Player 9.0 or later Flash player, 128 MB of RAM Monitor settings: High color at 800 x 600 pixels, sound card and speakers, Adobe Acrobat Reader.

ACTIVITY
Instructions
Please complete the pre-test, listen to and view the following presentation, and complete the post-test and evaluation to receive CNE credit for this activity. A statement of credit will be available online immediately following successful completion of the activity.

Pre-assessment

Introduction and Overview of Sleep and Narcolepsy
Kathy P. Parker, PhD, RN, APRN, FAAN

Symptom Identification and Diagnosis
Ann E. Rogers, PhD, RN, FAAN

Evidence-Based Treatment Decisions for Symptom Management
Mary C. Kapella PhD, MS, RN, and Ann E. Rogers, PhD, RN, FAAN

Emerging Landscape of Narcolepsy-Related EDS Patient Treatment
Ann E. Rogers, PhD, RN, FAAN

Nursing Role in Narcolepsy-Related EDS Patient Management
Mary C. Kapella PhD, MS, RN, and Christina Calamaro, PhD, CRNP

Conclusions
Terri E. Weaver, PhD, RN, FAAN

Post-assessment

Submit a case to review at meeting:


procced to pretest


spacer  
  spacer
Advanced Studies in Medicine © 2014 Contact Us
spacer  
spacer